Unchained Labs is a life science tools company focused on solving problems for biologics and gene therapy researchers. The solutions from Unchained Labs are used by biopharma researchers around the world to analyze and characterize large, complex molecules and to make their research jobs easier. Recently, the company announced plans to move its headquarters from a different Pleasanton site to Hacienda, where a host of other notable life sciences companies have also found a home.

In August, Unchained Labs began building its new, expanded campus on a 12-acre property at 4747 Willow Road. The property includes an existing 121,000-square-foot facility, and terms of the long-term lease give Unchained Labs the right to build additional buildings on the site to support future growth. The new building will be nearly three times the size of the company’s current footprint. All of the company’s California-based science, engineering, manufacturing, marketing, sales, and administrative functions will be consolidated into the new headquarters. Officials estimate it will take roughly one year to upgrade the site, including the buildout of lab and production space. The team expects to move into the new Hacienda facilities in mid-2023, according to officials.

“We are growing like crazy and busting at the seams,” says Tim Harkness, Founder and CEO of Unchained Labs. “The business has almost doubled over the past two  years, and we have already launched four new products this year. We have never been more optimistic about our future, and we needed a long-term facility plan that matched our growth expectations. This new campus is the perfect solution. Pleasanton is an ideal place to build a business and has become an important part of our identity. We are ecstatic to bring our full tribe together under one roof and to call Pleasanton our forever home.”

“We are thrilled to welcome Unchained Labs as our tenant to what will be one of the premier life science facilities in San Francisco’s East Bay,” according to Christopher Hayes, Managing Director of W. P. Carey, which is leasing the property to Unchained Labs. “We look forward to supporting them as they continue to execute on their strategic growth initiatives.”

Founded in 2015, Unchained Labs was acquired by global investment firm The Carlyle Group in 2021. "Unchained Labs sits at the intersection of one of the most attractive sectors in healthcare, life science tools, and its fastest growing end market, biopharma," said Steve Wise, Global Head of Healthcare at Carlyle, at the time. "With strong industry tailwinds, we believe Unchained Labs has significant growth opportunities and we're excited to support another founder-backed business to scale through investments in research and development, digitization, and geographic expansion."

Robert Schmidt, a Managing Director specializing in healthcare investing at Carlyle, added that "in the midst of the genomic revolution, Unchained Labs is on a mission to bring highly innovative products that are critical to drug development to researchers globally. We look forward to partnering with Tim and his impressive management team as they help their pharma and biotech customers work on critical scientific discoveries and accelerate the company's aggressive growth plans."

For more information about Unchained Labs, please visit www.unchainedlabs.com and its YouTube channel at www.youtube.com/c/UnchainedLabs.